Article
Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions.
Biochemical pharmacology - 15 Nov 2016
Banerjee Mayukh, Marensi Vanessa, Conseil Gwenaëlle, Le X Chris, Cole Susan P C, Leslie Elaine M
Abstract excerpt
Broad inter-individual variation exists in susceptibility to arsenic-induced tumours, likely involving differences in the ability of individuals to eliminate this metalloid. We recently identified human multidrug resistance protein 4 (MRP4/ABCC4) as a novel pathway for the cellular export of dimethylarsinic acid (DMAV), the major urinary arsenic metabolite in humans, and the diglutathione conjugate of the highly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
